Cholangio Carcinoma
4
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Open Surgery
Research Leaders
20 sponsors active, led by Helsinki University Central Hospital
Related Conditions
Often studied with 18 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Treatment for Bile Duct Cancer in the Liver
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)
Research Network
Common Treatments
- Open Surgery1
- Sirt Yttrium901
- Laparoscopic Surgery1
- Hop Bundle1
Active Sponsors
- Helsinki University Central Hospital1
- Maastricht University Medical Center1
- University Medical Center Groningen1
- University of Nottingham1
- Leiden University Medical Center1
Top Investigators
University of Nottingham
Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
Department of Clinical Oncology, The Chinese University of Hong Kong
Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
Related Conditions
- Biliary Tract Cancer Btc1
- Mucinous Cystic Neoplasm1
- Pancreas Head Cancer1
- Duodenal Adenocarcinoma1
- Pdac Pancreatic Ductal Adenocarcinoma1